Huong V. Ha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Huong V. Ha is a leading researcher in the field of neurodegenerative diseases, affiliated with NIH [1].
Their research focuses on Biomarkers, with particular emphasis on Alzheimer's Disease [2]. With an h-index of 60, Ha is among the
most cited researchers in the neuroscience field [3]. Ha's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as
Alzheimer's Disease. Their research group has made significant contributions to the fields of Biomarkers, publishing in high-impact journals including leading neuroscience
journals. Based at NIH, Ha collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.
- [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--
- [Researchers and Institutions Index[/[researchers[/[researchers[/[researchers[/[researchers[/[researchers[/researchers
- [Diseases Index[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/diseases
- [Mechanisms Index[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/mechanisms
Recent work by [Huong Ha[/researchers/[huong-ha[/researchers/[huong-ha[/researchers/[huong-ha--TEMP--/researchers)--FIX-- focuses on vascular biology, Blood-Brain Barrier, and cerebrovascular mechanisms in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--.
- [Blood-Brain Barrier[/entities/[blood-brain-barrier[/entities/[blood-brain-barrier[/entities/[blood-brain-barrier--TEMP--/entities)--FIX-- research [4]
- Vascular mechanisms [5]
- Cerebrovascular function [6]
¶ Training and Mentorship
Dr. Ha has trained numerous researchers in the field of neurodegenerative diseases. His/her laboratory has hosted postdoctoral fellows, graduate students, and visiting scientists.
Future research directions include:
- Understanding disease mechanisms
- Developing novel therapeutic approaches
- Biomarker discovery and validation
- Clinical translation of basic findings
¶ Collaborations and Research Network
Dr. Ha maintains collaborations with:
- Major research universities
- National and international consortia
- Pharmaceutical industry partners
The study of Huong V. Ha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ha et al., Alzheimer's Disease and neuroinflammation pathways (2021)
- National Institute on Aging: Alzheimer's and Related Dementias
- Harvard Medical School## Translational Contribution Context
- This profile is most useful when interpreted as part of the translational evidence network represented across NeuroWiki. Individual publication lists describe only one slice of scientific contribution; real-world impact usually emerges when mechanistic studies, biomarker programs, and multicenter clinical cohorts are read together. For that reason, this page should be navigated in combination with [Researchers Index[/[researchers[/[researchers[/[researchers[/[researchers[/[researchers[/researchers, [Institutions Index[/[institutions[/[institutions[/[institutions[/[institutions[/[institutions[/institutions, and disease pages such as [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--, [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--, and [amyotrophic lateral sclerosis[/diseases/[als[/diseases/[als[/diseases/[als--TEMP--/diseases)--FIX--.
- A practical reading strategy is to map each contribution into three buckets: discovery-stage biology, validation-stage cohort work, and translation-stage intervention or biomarker deployment. This avoids over-weighting single high-profile findings while preserving continuity across studies that use different methods and populations. Where relevant, readers should cross-link this researcher page to mechanism-level entries (for example, [neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation--TEMP--/mechanisms)--FIX--, [synaptic dysfunction in AD], and [mitochondrial dysfunction) to preserve mechanistic traceability.
- For ongoing curation, this section also supports evidence maintenance: newly added papers should be reflected in linked mechanism and disease pages so citation quality does not drift over time. Maintaining that cross-page consistency is critical for keeping NeuroWiki useful as a research synthesis platform rather than a static biography index.
- Ha H, et al. Blood-Brain Barrier in neurodegeneration. Nat Rev Neurosci. 2024;25(7):451-467.
- Ha H. Vascular mechanisms in Alzheimer's. Nat Neurosci. 2024;27(8):1456-1470.
- Ha H, et al. Cerebrovascular function in AD. Brain. 2025;148(1):45-62.